PYXS Pyxis Oncology Inc
Company Analysis
Latest News
🟢 Pyxis Oncology is trading 7% up today in after-hours trading amid broader-market strength
Pyxis Oncology is trading 6.98% up now at $3.30 in after-hours trading, with the move appearing more consistent with favorable broader-market sentiment than a...
🔴 Pyxis Oncology falls 5.3% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
🟢 Pyxis Oncology is trading 10% up today after positive melanoma vaccine results
Pyxis Oncology is trading 10.03% up now at $3.29, with the move appearing primarily sector-driven after Moderna and Merck reported positive Phase 3 melanoma...
🔴 Pyxis Oncology is trading 5.32% down today after reporting a $25.3 million second-quarter net loss
Pyxis Oncology is trading 5.32% down at $2.85 as investors continue reassessing its August 13, 2026 quarterly results and $25.3 million second-quarter net...
Pyxis Oncology Bought Itself Time With a $50 Million Lifeline — But Can the Data Deliver Before the Cash Runs Out Again?
Shares of Pyxis Oncology jumped 10% to $3.31 on August 14, the day after the clinical-stage biotech reported a wider second-quarter loss but reassured Wall...
🟢 Pyxis Oncology is trading 10% up today in pre-market after private placement extends runway into 2027
Pyxis Oncology is trading at $3.31, +9.97% in pre-market on August 14, 2026, as investors appear focused on a private placement extending its operating runway...
🔴 Pyxis Oncology is trading 5.66% down in pre-market after a wider-than-expected second-quarter loss
Pyxis Oncology is trading 5.66% down at $3.00 after reporting a second-quarter 2026 loss of $0.40 per share versus the expected $0.34. - The company reported...
Pyxis Oncology missed second quarter estimates with a $0.40 loss while extending runway to 2027
Pyxis Oncology reported a wider-than-expected net loss of $0.40 per share for the second quarter 2026, missing analyst estimates of a $0.34 loss. The company...
🟢 Pyxis Oncology is trading 10% up today on broader risk-on sentiment
Pyxis Oncology is trading 10.25% up at $3.12, with the move appearing mainly tied to broader risk-on sentiment alongside possible positioning around an...
🟢 Pyxis Oncology is trading 7.77% up today amid risk-on sentiment and possible earnings positioning
Pyxis Oncology is trading 7.77% up at $3.05, with broader risk-on sentiment and positioning around an estimated earnings release potentially supporting the...
🟢 Pyxis Oncology is trading 9.05% up today with no clear catalyst as earnings approach
Pyxis Oncology is trading 9.05% up at $3.09 after rebounding from the August 11, 2026 close, without a new company-specific announcement clearly explaining the...
Pyxis Oncology Inc Q2 2026 Earnings Preview: What Analysts Expect on August 13, 2026
Wall Street analysts expect Pyxis Oncology to report a second-quarter loss of $0.34 per share on nominal revenue of $0.033 million, with its current $3.89...
🔴 Pyxis Oncology is trading 8.62% down today after reversing recent gains
Pyxis Oncology is trading 8.62% down at $3.50 after a sharp reversal from recent gains. - Recent gains included a 19.81% rise on August 6 and a 14.72% rise on...
🟢 Pyxis Oncology is trading 5% up today after recent gains
Pyxis Oncology is trading 5.09% up now at $3.92, extending recent volatility after gains of 19.81% on August 6 and 14.72% on August 3. - No new company press...
🟢 Pyxis Oncology Inc is trading 10.22% up
PYXS is trading at $3.45, up 10.22%.
🟢 Pyxis Oncology is trading 6% up today as $50 million financing extends runway
Pyxis Oncology is trading 6% up now at $3.32 as its recent financing-driven rebound continued on August 6, 2026. - The private placement raised approximately...
🟢 Pyxis Oncology is trading 5% up today as financing-driven rally extends
Pyxis Oncology is trading 5% up today at $3.32, extending a sharp multi-session rebound following a recent $50 million private placement. • The financing...
🔴 Pyxis Oncology is trading 6% down today after a recent financing-driven rally
Pyxis Oncology is trading 6% down at $2.97 in pre-market, pulling back after sharp gains over the last two sessions. • The stock recently jumped on a $50...
🟢 Pyxis Oncology is trading 5% up today following a $50M private placement and positive analyst commentary
Pyxis Oncology is trading approximately 5% higher at $3.19 as the stock stabilizes following the announcement of a $50 million private placement. • The...
🔴 Pyxis Oncology is trading 5.6% down today following a $50 million private placement and analyst updates
Pyxis Oncology is trading at $2.87 (5.6% down) in pre-market on August 4, 2026, easing after a sharp rebound in the prior session. • The company recently...